Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cutaneous mosaic RASopathies associated with rhabdomyosarcoma.
Davies OMT, Bruckner AL, McCalmont T, Mascarenhas L, Oza V, Williams ML, Wine-Lee L, Shern JF, Siegel DH. Davies OMT, et al. Among authors: mascarenhas l. Pediatr Blood Cancer. 2022 May;69(5):e29639. doi: 10.1002/pbc.29639. Epub 2022 Mar 6. Pediatr Blood Cancer. 2022. PMID: 35253347 Review.
Survival outcomes of patients with localized FOXO1 fusion-positive rhabdomyosarcoma treated on recent clinical trials: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.
Heske CM, Chi YY, Venkatramani R, Li M, Arnold MA, Dasgupta R, Hiniker SM, Hawkins DS, Mascarenhas L. Heske CM, et al. Among authors: mascarenhas l. Cancer. 2021 Mar 15;127(6):946-956. doi: 10.1002/cncr.33334. Epub 2020 Nov 20. Cancer. 2021. PMID: 33216382 Free PMC article.
Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.
Pacenta HL, Allen-Rhoades W, Langenau D, Houghton PJ, Keller C, Heske CM, Deel MD, Linardic CM, Shern JF, Stewart E, Turpin B, Harrison DJ, Khan J, Mascarenhas L, Skapek SX, Meyer WH, Hawkins DS, Chen EY, Amatruda JF, Hingorani P, Laetsch TW. Pacenta HL, et al. Among authors: mascarenhas l. J Clin Med. 2021 Apr 1;10(7):1416. doi: 10.3390/jcm10071416. J Clin Med. 2021. PMID: 33915882 Free PMC article. Review.
Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group.
Crane JN, Xue W, Qumseya A, Gao Z, Arndt CAS, Donaldson SS, Harrison DJ, Hawkins DS, Linardic CM, Mascarenhas L, Meyer WH, Rodeberg DA, Rudzinski ER, Shulkin BL, Walterhouse DO, Venkatramani R, Weiss AR. Crane JN, et al. Among authors: mascarenhas l. Pediatr Blood Cancer. 2022 Jun;69(6):e29644. doi: 10.1002/pbc.29644. Epub 2022 Mar 6. Pediatr Blood Cancer. 2022. PMID: 35253352 Free PMC article. Review.
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.
Akshintala S, Sundby RT, Bernstein D, Glod JW, Kaplan RN, Yohe ME, Gross AM, Derdak J, Lei H, Pan A, Dombi E, Palacio-Yance I, Herrera KR, Miettinen MM, Chen HX, Steinberg SM, Helman LJ, Mascarenhas L, Widemann BC, Navid F, Shern JF, Heske CM. Akshintala S, et al. Among authors: mascarenhas l. Clin Cancer Res. 2023 Sep 1;29(17):3329-3339. doi: 10.1158/1078-0432.CCR-23-0709. Clin Cancer Res. 2023. PMID: 37398992 Free PMC article. Clinical Trial.
Treatment of infantile choriocarcinoma of the liver.
Yoon JM, Burns RC, Malogolowkin MH, Mascarenhas L. Yoon JM, et al. Among authors: mascarenhas l. Pediatr Blood Cancer. 2007 Jul;49(1):99-102. doi: 10.1002/pbc.20623. Pediatr Blood Cancer. 2007. PMID: 16206190
285 results